» Articles » PMID: 30524162

The Importance of Acinetobacter Species in the Hospital Environment

Overview
Journal Med Arch
Specialty General Medicine
Date 2018 Dec 8
PMID 30524162
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: species is associated with health care associated infections especially in patients on respiratory therapy equipment and indwelling catheters. They are becoming increasingly drug resistant. The knowledge of the prevalence and pattern of antimicrobial susceptibility pattern of Acinetobacter spp. is important.

Aims: The study is undertaken to estimate the prevalence rate, risk factors and antimicrobial resistance pattern of isolates. in spp. from various clinical samples.

Material And Methods: The isolates of species obtained from various clinical specimen. Specimens were processed by standard microbiological techniques. Antimicrobial sensitivity tests of the isolates were done by modified Kirby-Bauer disc diffusion method.

Results: Out of 622 isolates, 399 isolates were from inpatients (62,18%) and 223 were from outpatients (37,82%). More than 90% of isolates displayed resistance to ampicillin, amoxicillin-clavulanic acid, ceftazidime, caftriaxon and amikacin. Resistance to gentamicin, co-trimoxazole and ciprofloxacin were also common. Least resistance was seen to piperacillin-tazobactam and imipenem. A total of 125 Acinetobacter isolates were analyzed, out of which 78.4 % were multi-drug resistant (MDR). Of these MDR isolates, 17.24% were pan-resistant. was the most common species responsible for wound infection (84,8%), pneumonia(96,15%), abscess (72.7%), urinary tract infection (85,7%) and septicemia(89,5%).

Conclusion: Multi-drug resistant has emerged as an important nosocomial pathogen. Antibiotic susceptibility testing is critical in the treatment of infections caused by Continued surveillance of prevalent organisms in ICUs, combined with preventive measures remains absolutely essential in efforts to prevent or limit the spread of infection.

Citing Articles

Antimicrobial resistance profile and associated factors of hospital-acquired gram-negative bacterial pathogens among hospitalized patients in northeast Ethiopia.

Tilahun M, Sharew B, Shibabaw A BMC Microbiol. 2024; 24(1):339.

PMID: 39261762 PMC: 11389124. DOI: 10.1186/s12866-024-03485-0.


An Analysis of the Contaminants on Otoscopes of Otolaryngology Residents: An Observational Study.

Havaldar R, Vagarali M, Belaldavar B, Redkar A, Boral P Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3386-3389.

PMID: 39130216 PMC: 11306819. DOI: 10.1007/s12070-024-04695-8.


Medical Device-Associated Infections Caused by Biofilm-Forming Microbial Pathogens and Controlling Strategies.

Mishra A, Aggarwal A, Khan F Antibiotics (Basel). 2024; 13(7).

PMID: 39061305 PMC: 11274200. DOI: 10.3390/antibiotics13070623.


Medical Device-Associated Healthcare Infections: Sterilization and the Potential of Novel Biological Approaches to Ensure Patient Safety.

Garvey M Int J Mol Sci. 2024; 25(1).

PMID: 38203372 PMC: 10778788. DOI: 10.3390/ijms25010201.


Prevalence and antimicrobial susceptibility of spp. in a tertiary care hospital in Peshawar: a cross-sectional study.

Ahmad S, Shakireen N, Ali Khan M, Mumtaz H, Ahmad W, Shah M Ann Med Surg (Lond). 2023; 85(5):1584-1589.

PMID: 37228944 PMC: 10205259. DOI: 10.1097/MS9.0000000000000117.


References
1.
Sivaranjani V, Umadevi S, Srirangaraj S, Kali A, Seetha K . Multi-drug resistant Acinetobacter species from various clinical samples in a tertiary care hospital from South India. Australas Med J. 2014; 6(12):697-700. PMC: 3877852. DOI: 10.4066/AMJ.2013.1901. View

2.
Rodriguez-Bano J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros J, Pachon J . Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008; 14(3):276-8. DOI: 10.1111/j.1469-0691.2007.01916.x. View

3.
Shete V, Ghadage D, Muley V, Bhore A . Acinetobacter septicemia in neonates admitted to intensive care units. J Lab Physicians. 2011; 1(2):73-6. PMC: 3167973. DOI: 10.4103/0974-2727.59704. View

4.
Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y . Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis. 2005; 11(1):22-9. PMC: 3294361. DOI: 10.3201/eid1101.040001. View

5.
Humphries R, Bobenchik A, Hindler J, Schuetz A . Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition. J Clin Microbiol. 2021; 59(12):e0021321. PMC: 8601225. DOI: 10.1128/JCM.00213-21. View